Long-term effects of troglitazone: Open-label extension studies in type 2 diabetic patients

Diabetes Care

Volumn 23, Issue 3, 2000, Pages 354-359

  Fonseca, Vivian ^a   Foyt, Howard L ^b   Shen, Ke ^b   Whitcomb, Randall ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL; TROGLITAZONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAXIMUM PERMISSIBLE DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034088987     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.3.354     Document Type: Article

References (20)